Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol
Authors:
- Lara R. DugasLara R. Dugas
- Louise LieLLLouise Lie
- Jacob Plange-RhuleJPJacob Plange-Rhule
- Kweku Bedu-AddoKBKweku Bedu-Addo
- Pascal BovetPascal Bovet
- Estelle V. LambertELEstelle V. Lambert
- Terrence E. ForresterTFTerrence E. Forrester
- Amy LukeALAmy Luke
- Jack A. GilbertJGJack A. Gilbert
- Brian T. LaydenBLBrian T. Layden
Open Access
- 6 August 2018
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 978
Abstract
While some of the variance observed in adiposity and weight change within populations can be accounted for by traditional risk factors, a new factor, the gut microbiota, has recently been associated with obesity. However, the causal mechanisms through which the gut microbiota and its metabolites, short chain fatty acids (SCFAs) influence obesity are unknown, as are the individual obesogenic effects of the individual SCFAs (butyrate, acetate and propionate). This study, METS-Microbiome, proposes to examine the influence of novel risk factors, the gut microbiota and SCFAs, on obesity, adiposity and weight change in an international established cohort spanning the epidemiologic transition. The parent study; Modeling the Epidemiologic Transition Study (METS) is a well-established and ongoing prospective cohort study designed to assess the association between body composition, physical activity, and relative weight, weight gain and cardiometabolic disease risk in five diverse population-based samples in 2500 people of African descent. The cohort has been prospectively followed since 2009. Annual measures of obesity risk factors, including body composition, objectively measured physical activity and dietary intake, components which vary across the spectrum of social and economic development. In our new study; METS-Microbiome, in addition to continuing yearly measures of obesity risk, we will also measure gut microbiota and stool SCFAs in all contactable participants, and follow participants for a further 3 years, thus providing one of the largest gut microbiota population-based studies to date. This new study capitalizes upon an existing, extensively well described cohort of adults of African-origin, with significant variability as a result of the widespread geographic distributions, and therefore variation in the environmental covariate exposures. The METS-Microbiome study will substantially advance the understanding of the role gut microbiota and SCFAs play in the development of obesity and provide novel obesity therapeutic targets targeting SCFAs producing features of the gut microbiota. Registered NCT03378765 Date first posted: December 20, 2017.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK111848)
This publication has 95 references indexed in Scilit:
- Gut Microbiota Composition in Male Rat Models under Different Nutritional Status and Physical Activity and Its Association with Serum Leptin and Ghrelin LevelsPLOS ONE, 2013
- Metagenomic microbial community profiling using unique clade-specific marker genesNature Methods, 2012
- Quantification of the effect of energy imbalance on bodyweightThe Lancet, 2011
- Dominant and diet-responsive groups of bacteria within the human colonic microbiotaThe ISME Journal, 2010
- Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathwayAmino Acids, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Associations between obesity and serum lipid-soluble micronutrients among premenopausal womenNutrition Research, 2010
- Energy Expenditure and Adiposity in Nigerian and African‐American WomenObesity, 2008
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006